EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Antimalarial Adherence and Risk of Cardiovascular Events in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study

Md Rashedul Hoque iD, J Antonio Aviña-Zubieta iD, Diane Lacaille iD, Mary A De Vera, Yi Qian, Lawrence McCandless, John M Esdaile, Hui Xie iD

Arthritis Care & Research · 2024-03 · 76 (3) · 426-436

DOI: 10.1002/acr.25233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis Care & Research, online erschienen am 18.12.2023. Verfasst von Md Rashedul Hoque und 7 weiteren Autor:innen. Beteiligte Einrichtung: Arthritis Research Canada, Vancouver, and Simon Fraser University, Burnaby, British Columbia, Canada. Hauptthemen laut MEDLINE: Antimalarials, Venous Thromboembolism, Lupus Erythematosus, Systemic, Arthritis, Rheumatoid. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aimed to assess the association between antimalarial adherence and cardiovascular events between incident rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) population‐based cohorts.

Methods

All patients with incident RA/SLE and incident antimalarial use in British Columbia, Canada, between January 1997 and March 2015 were identified using provincial administrative databases. The outcomes were incident cardiovascular events, including myocardial infarction (MI), stroke, or venous thromboembolism (VTE). The exposure was antimalarial adherence with levels: discontinuation (proportion of days covered [PDC = 0]), nonadherence (0 < PDC < 0.90), and adherence (PDC ≥ 0.90). We used marginal structural models to estimate the effect of antimalarial adherence on the rate of cardiovascular events, accounting for potential confounders.

Results

We identified 16,538 individuals with incident RA/SLE and incident antimalarial use without any cardiovascular event before the index date. Over nine years mean follow‐up, 2,174 incident cardiovascular events (13.2%) were observed. The adjusted hazard ratio (aHR) for incident cardiovascular events for antimalarial adherence relative to discontinuation was 0.72 (95% confidence interval [CI] 0.64–0.81) and 1.01 (95% CI 0.90–1.14) for nonadherence. Additionally, the aHRs for all cardiovascular events, MI, stroke, and VTE for adherence relative to nonadherence was 0.71 (95% CI 0.61–0.82), 0.62 (95% CI 0.51–0.75), 0.45 (95% CI 0.36–0.58), and 0.65 (95% CI 0.46–0.93), respectively. We found older age modified the association between antimalarial adherence and cardiovascular events ( P = 0.02).

Conclusion

When people newly diagnosed with RA or SLE take their antimalarial regularly as prescribed (PDC ≥ 0.90), they have a 29% lower risk of sustaining a cardiovascular event than patients with a lower degree of adherence (PDC < 0.90) and a 28% lower risk than if they discontinue antimalarials. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsVenous ThromboembolismLupus Erythematosus, SystemicArthritis, RheumatoidMyocardial InfarctionStrokeHumansBritish ColumbiaRisk Factors

Substanzen

Antimalarials

Autor:innen und Institutionen

  • Arthritis Research Canada, Vancouver, and Simon Fraser University, Burnaby, British Columbia, Canada.
  • Arthritis Research Canada and University of British Columbia, Vancouver, British Columbia, Canada.
  • University of British Columbia, Vancouver, British Columbia, Canada.
  • Simon Fraser University, Burnaby, British Columbia, Canada.

ORCID-Profile: Md Rashedul Hoque, J Antonio Aviña-Zubieta, Diane Lacaille, Hui Xie

Förderung

  • CIHR
  • Canadian Institutes of Health Research
  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Hoque, M. R., Aviña-Zubieta, J. A., Lacaille, D., De Vera, M. A., Qian, Y., McCandless, L., Esdaile, J. M., & Xie, H. (2024). Antimalarial Adherence and Risk of Cardiovascular Events in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study. Arthritis Care & Research, 76(3), 426-436. https://doi.org/10.1002/acr.25233

Vancouver

Hoque MR, Aviña-Zubieta JA, Lacaille D, De Vera MA, Qian Y, McCandless L, et al. Antimalarial Adherence and Risk of Cardiovascular Events in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study. Arthritis Care & Research. 2024;76(3):426-436. doi:10.1002/acr.25233

BibTeX
@article{Hoque2024,
  author = {Hoque, Md Rashedul and Aviña-Zubieta, J Antonio and Lacaille, Diane and De Vera, Mary A and Qian, Yi and McCandless, Lawrence and Esdaile, John M and Xie, Hui},
  title = {Antimalarial Adherence and Risk of Cardiovascular Events in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study},
  journal = {Arthritis Care & Research},
  year = {2024},
  volume = {76},
  number = {3},
  pages = {426--436},
  doi = {10.1002/acr.25233}
}
Kostenlos starten →